Investigator's Responsibilities

1572 Responsibilities (MS Word)
Good Clinical Practice in FDA Regulated Clinical Trials
Code of Federal Regulations (CFR)

a. Investigational New Drugs - 21 CFR Part 312
b. Investigational New Drug Responsibilities of Investigators - 21 CFR Part 312.60-312.70
c. Financial Disclosure by Clinical Investigators - 21 CFR Part 54
d. Investigational Device Exemptions - 21 CFR Part 812
e. Protection of Human Subjects - 21 CFR Part 50
Common Rule, Protection of Human Subjects, Federal Register 45 Part 46
FDA Information Sheets

This page last updated: October, 28, 2010

The University of Kansas
Medical Center
Research Institute
6003 Wescoe Pavilion
Mail Stop 1039
3901 Rainbow Boulevard
Kansas City, KS 66160
Phone: 913-588-1249
Fax: 913-588-5729
E-Mail: mgunter@kumc.edu

© The University of Kansas Medical Center
About this Site | An EO/AA/Title IX Institution | Privacy Statement | Site Index | Help